• CellCept, Cyclophosphamide Both Improve Patient-reported Outcomes in SSc-ILD, Phase 2 Data Show
  • Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic
  • Rheumatology Expert to Lead Scleroderma Program at Cedars-Sinai’s Kao Institute
  • Shear-wave Elastography May Best Capture Changes in Skin Stiffness
  • Coalition Will Address Racial Disparities in Rare Disease Communities
  • Virtual Walks, Other Activities to Spotlight Scleroderma Awareness Month
  • TLY012 Receives FDA Orphan Drug Status for Systemic Scleroderma
  • COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say
  • Eurordis Urges Expansion of Newborn Screening Initiatives Across Europe
  • Unity and EU-wide Efforts Focus of Online Rare Disease Meeting
  • Experts Issue Guidance for Care of Scleroderma Patients During COVID-19
  • Rare Diseases Clinical Research Network Opens Online Survey on COVID-19